Long-term debt · 2016–2025
Axsome Therapeutics long-term debt
$118M−34.8% · FY2025
Axsome Therapeutics (AXSM) reported $118M in long-term debt for fiscal 2025, −34.8% year on year.
| Fiscal year | Long-term debt | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $118M | −34.8% | Open → |
| FY20242024-12-31 | $181M | +1.5% | Open → |
| FY20232023-12-31 | $178M | +88.9% | Open → |
| FY20222022-12-31 | $94.3M | +92.0% | Open → |
| FY20212021-12-31 | $49.1M | +1.6% | Open → |
| FY20202020-12-31 | $48.3M | +178.8% | Open → |
| FY20192019-12-31 | $17.3M | +378.9% | Open → |
| FY20182018-12-31 | $3.6M | −45.7% | Open → |
| FY20172017-12-31 | $6.7M | −29.6% | Open → |
| FY20162016-12-31 | $9.5M | — | Open → |
Long-term debt — Long-term debt is borrowing due more than a year out. A large figure is normal for capital-intensive businesses and says nothing on its own about financial health.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2016–2025 compound annual growth +32.3%
Long-term debt at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Axsome Therapeutics long-term debt |url=https://companiesranked.com/en/company/axsome-therapeutics/long-term-debt |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Axsome Therapeutics long-term debt. CompaniesRanked. https://companiesranked.com/en/company/axsome-therapeutics/long-term-debtBibTeX
@misc{companiesranked-en-company-axsome-therapeutics-long-term-debt-2026,
author = {{CompaniesRanked}},
title = {{Axsome Therapeutics long-term debt}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/axsome-therapeutics/long-term-debt}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001193125-26-342360 · August 10, 2026
{{cite web |title=Axsome Therapeutics long-term debt — 10-Q (0001193125-26-342360) |url=https://www.sec.gov/Archives/edgar/data/1579428/000119312526342360/axsm-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-10}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.